Abstract:BACKGROUND: Vaccine-induced antitumor CD8(superscript +) T-cell responses are believed to play an important role in increasing resistance to carcinoma. Research shows that after uptake of fusion proteins of heat-shock protein 70 (HSP70) with tumor associated antigen into antigen presenting cells, processing and representation of heat-shock protein-chaperoned peptides on MHC class I molecules, a CD8(superscript +) cytotoxic T lymphocyte response is initiated. OBJECTIVE: To construct and identify eukaryotic expression vector of melanoma antigen gene 3 MAGE-3-HSP70. DESIGN, TIME AND SETTING: A single sample observation was completed at Key Laboratory of Nano-biotechnology, National Ministry of Health from June to December 2008. MATERIALS: The eukaryotic vector pcDNA3.1 (-) was purchased from BD Company. The vector pINCY/MAGE-3 and pOTB7/HSP70 were purchased from Open Biosystems Company. DH5α were preserved at Key Laboratory of Nano-biotechnology, National Ministry of Public Health, China. METHODS: A pair of MAGE-3 primers containing Xho Ⅰ restriction site and HSP70 primers containing Kpn Ⅰ restriction site were designed. pINCY/MAGE-3 and pOTB7/HSP70 were used as template to amplify MAGE-3 and HSP70 gene by polymerase chain reaction (PCR). MAGE-3 upstream primer (containing Xho Ⅰ restriction site) and HSP70 downstream primer (containing Kpn Ⅰ restriction site) were used as template to amplify MAGE-3-HSP70 fusion gene fragments. The PCR products and empty plasmid pcDNA 3.1 (-) were digested by XhoⅠ and Kpn Ⅰ, ligated, then transformed competence E. coli DH5α. Positive clones were identified by restriction endonuclease digestion and sequencing. MAIN OUTCOME MEASURES: The identification of pcDNA3.1 (-)/MAGE-3-HSP70 fusion gene eukaryotic expression vector. RESULTS: Sequencing results showed that the MAGE-3 gene in the vector was in coincidence with the sequence registered in Gene Bank and the HSP70 had three synonymous mutations. CONCLUSION: MAGE-3-HSP70 fusion gene eukaryotic expression vector has been constructed successfully.

Cloning and expression of human melanoma antigen MAGE-A10

Proliferative effect of MAGE-A9 deletion mutant on human breast cancer MCF-7 cells

Cloning and prokaryotic expression of tumor antigen MAGE-A9

Cloning, Prokaryotic Expression, and Antibody Preparation of Human MAGE-1

Cloning and sequencing the melanoma-associated antigen E1 gene

Cloning of Human Testicular Carcinoma Antigen MAGE-E1 Gene and Its Expression in E.coli

Prokaryotic Expression,purification and Identification of MAGE-D4a

Prokaryotic Expression and Purification of MAGE-3 Gene and Preparation of Polyclonal Antibody Against MAGE-3

Construction,expression and purification of a fusion gene of MAGE-n peptide with human heat shock protein 70

Selection and Characterization of Human Anti-MAGE-A1 Scfv and Immunotoxin

Expression of MAGE-A10 Protein and Its Clinical Significance in Human Lung Cancer

Magea10 Gene Expression In Non-Small Cell Lung Cancer And A549 Cells, And The Affinity Of Epitopes With The Complex Of Hla-A*0201 Alleles

Identification of a New MAGE-A10 Antigenic Peptide Presented by HLA-A*0201 on Tumor Cells

Establishment of Mouse Melanoma B16 Cell Lines Which Stably Express Human MAGE - 1

MAGE-1 and Related MAGE Gene Expression May Be Associated with Hepatocellular Carcinoma

Construction and immunologic competence of MAGE-1 gene vaccine

Expression of Melanoma Antigen Gene in Cell Lines Originated from Hepatocellular Carcinoma Cells

Construction and Identification of Eukaryotic Expression Vector of MAGE-3-HSP70 Fusion Gene

Tissue Expression Profile of Human MAGE-D1, the New Member of Melanoma Antigen-encoding Gene Family

Establishment of antigen MAGE-3 gene vaccine and primary study of its immune activity

The effect of MAGE-A1 gene on NIH3T3 cells